Condition
Primary Generalized Tonic-Clonic Seizures clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Primary Generalized Tonic-Clonic Seizures clinical trials that are recruiting, at sites in 21 countries (most in Argentina (1), Australia (1), Austria (1)). By phase: Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 21Countries
All recruiting trials (2)
-
Evaluating the safety of Fycompa injection for seizures
This study is testing the safety of a new injection called Fycompa for people with epilepsy who have certain types of seizures.
-
Evaluating XEN1101 for treating primary generalized tonic-clonic seizures
This study is testing a new medication called XEN1101 to see if it can help people aged 12 and older with primary generalized tonic-clonic seizures who are still having seizures despite taking other medications.
Quick answers
How many Primary Generalized Tonic-Clonic Seizures clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 21 countries. The most sites are in Argentina (1 trial), Australia (1 trial), Austria (1 trial), Belgium (1 trial), Bulgaria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.